10-KThe Record
Enliven Therapeutics, Inc. files 10-K
Filed Feb 10, 2023 · 3y ago · Accession 0001564590-23-001729
Plain English
Annual report — full-year financials, business overview, and risk factors.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 10-K
- Filing date
- Feb 10, 2023
- Report date
- Dec 31, 2022
- Document
- imra-10k_20221231.htm
- Size
- 8.2 MB